Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Verve Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +13 vs. Q2 2023
- Shares held
- 63.9M
- +1.99M (+3.2%) vs. Q2 2023
- Total value
- $847.0M
- −$313.3M (−27.0%) vs. Q2 2023
- New holders
- 27
- 58 more added
- Sold out
- 14
- 24 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 4,823 | $64.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,991 | $52.9K | 0.00% | +3,041+320.1% | Added |
| Ci Investments Inc. | 3,756 | $50.0K | 0.00% | −112−2.9% | Reduced |
| Metropolitan Life Insurance Co | 3,201 | $42.4K | 0.00% | +403+14.4% | Added |
| Nisa Investment Advisors, LLC | 2,780 | $36.9K | 0.00% | −40−1.4% | Reduced |
| Sandy Spring Bank | 2,200 | $29.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,121 | $28.1K | 0.00% | −1,428−40.2% | Reduced |
| Lazard Asset Management LLC | 2,015 | $26.0K | 0.00% | +89+4.6% | Added |
| China Universal Asset Management Co., Ltd. | 1,641 | $21.8K | 0.01% | +829+102.1% | Added |
| Itau Unibanco Holding S.A. | 1,555 | $20.6K | 0.00% | +383+32.7% | Added |
| Group One Trading, L.P. | 1,353 | $17.9K | 0.00% | +1,353 | New |
| Cary Street Partner Investment Advisory LLC | 1,000 | $13.3K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 456 | $6.05K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 374 | $4.96K | 0.00% | +374 | New |
| Quadrant Capital Group LLC | 192 | $2.55K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 121 | $1.60K | 0.00% | +121 | New |
| C M Bidwell & Associates Ltd | 101 | $1.34K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 90 | $1.19K | 0.00% | +90 | New |
| Headinvest, LLC | 100 | $1.18K | 0.00% | +100 | New |
| EverSource Wealth Advisors, LLC | 79 | $1.05K | 0.00% | +79 | New |
| NBC Securities, Inc. | 150 | $1.00K | 0.00% | +150 | New |
| McIlrath & Eck, LLC | 75 | $995 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 53 | $703 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 47 | $623 | 0.00% | +47 | New |
| Massmutual Trust Co FSB | 22 | $292 | 0.00% | +22 | New |
| Northwestern Mutual Wealth Management Co | 7 | $93 | 0.00% | +7 | New |
| Cornerstone Planning Group LLC | 2 | $27 | 0.00% | +2 | New |
| Farther Finance Advisors, LLC | 2 | $27 | 0.00% | +2 | New |
| Allworth Financial LP | 1 | $14 | 0.00% | −97−99.0% | Reduced |
| IFP Advisors, Inc | 1 | $13 | 0.00% | −5−83.3% | Reduced |
| Sofos Investments, Inc. | 1 | $6 | 0.00% | −18−94.7% | Reduced |
| CWM, LLC | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 7 | $0 | 0.00% | −1−12.5% | Reduced |
| Capital Advisors, Ltd. LLC | 31 | $0 | 0.00% | +31 | New |
| Novo Holdings A/S | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −186,087−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −177,716−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −51,235−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −27,153−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,669−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,051−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,224−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −3,250−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −324−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Motco | 0 | $0 | 0.00% | −1−100.0% | Sold out |